Luminist Labs YC Demo Day (W16) - Diagnostic platform for early detection of liver disease
Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.
